Your Montana Public Radio
Wed April 10, 2013
Synthetic Malarial Drug Ingredient Could Cut Cost Of Treatment
Scientists have come up with a new way to produce the most common anti-malaria medicine currently on the market and a French pharmaceutical company is opening a new plant this week to manufacture it. The synthetic version of artemisinin is expected to stabilize the malaria medicine market and reduce the overall cost of malaria treatment.